This interview features Mark Emalfarb, president, CEO and director of OTCQX, and Matthew Jones, chief commercial officer of Dyadic International
In this video interview, Mark Emalfarb and Matthew Jones discuss how Dyadic is helping drug developers and manufacturers get to market faster.
This content is provided by OTC Markets and did not involve IR Magazine journalists.
